SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Phoenix, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Follow-Up Questions
Who is the CEO of Senestech Inc?
Mr. Joel Fruendt is the President of Senestech Inc, joining the firm since 2022.
What is the price performance of SNES stock?
The current price of SNES is $4.76, it has increased 1.59% in the last trading day.
What are the primary business themes or industries for Senestech Inc?
Senestech Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is Senestech Inc market cap?
Senestech Inc's current market cap is $23.5M
Is Senestech Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Senestech Inc, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
